Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $2.07.

  • Collegium Pharmaceutical's Debt to Equity fell 2288.15% to $2.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.07, marking a year-over-year decrease of 2288.15%. This contributed to the annual value of $2.69 for FY2024, which is 2973.33% up from last year.
  • Collegium Pharmaceutical's Debt to Equity amounted to $2.07 in Q3 2025, which was down 2288.15% from $2.52 recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Debt to Equity peaked at $3.2 during Q1 2022, and registered a low of $0.49 during Q3 2021.
  • In the last 5 years, Collegium Pharmaceutical's Debt to Equity had a median value of $2.51 in 2023 and averaged $2.11.
  • Per our database at Business Quant, Collegium Pharmaceutical's Debt to Equity crashed by 5446.04% in 2021 and then skyrocketed by 50857.34% in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Debt to Equity (Quarter) stood at $0.54 in 2021, then surged by 430.2% to $2.87 in 2022, then fell by 27.9% to $2.07 in 2023, then grew by 29.73% to $2.69 in 2024, then dropped by 22.84% to $2.07 in 2025.
  • Its Debt to Equity stands at $2.07 for Q3 2025, versus $2.52 for Q2 2025 and $2.56 for Q1 2025.